KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Receivables - Other: 2019-2025

Historic Receivables - Other for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $5.1 million.

  • Guardant Health's Receivables - Other rose 10.87% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year increase of 10.87%. This contributed to the annual value of $3.4 million for FY2024, which is 30.61% down from last year.
  • Guardant Health's Receivables - Other amounted to $5.1 million in Q3 2025, which was up 34.21% from $3.8 million recorded in Q2 2025.
  • Guardant Health's 5-year Receivables - Other high stood at $30.9 million for Q3 2021, and its period low was $3.1 million during Q1 2022.
  • Over the past 3 years, Guardant Health's median Receivables - Other value was $4.4 million (recorded in 2023), while the average stood at $4.6 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first skyrocketed by 307.14% in 2021, then crashed by 83.50% in 2022.
  • Over the past 5 years, Guardant Health's Receivables - Other (Quarterly) stood at $5.7 million in 2021, then declined by 5.26% to $5.4 million in 2022, then decreased by 9.26% to $4.9 million in 2023, then slumped by 30.61% to $3.4 million in 2024, then climbed by 10.87% to $5.1 million in 2025.
  • Its last three reported values are $5.1 million in Q3 2025, $3.8 million for Q2 2025, and $4.2 million during Q1 2025.